Amphetamine induces hypermotility in MPTP-lesioned mice

Pharmacol Biochem Behav. 1997 Feb;56(2):281-5. doi: 10.1016/s0091-3057(96)00291-2.

Abstract

Two strains of mice (NMRI and C57B1/ 6) were treated with MPTP (within 8 h 4 x 30 mg/kg MPTP, IP) and motility was monitored 10 days later. An acute administration of amphetamine (2.5 mg/kg or 10.0 mg/kg) or apomorphine (0.5 mg/kg or 5.0 mg/kg) led to hypermotility and a dose-dependent increase of stereotyped behavior. Immunocytochemical investigations indicated a substantial loss of tyrosine-hydroxylase immunoreactivity in the basal ganglia which was accompanied by a 15% increase of 3H-spiroperidol binding to a striatal membrane preparation. No difference was found in biochemical and behavioral measures between both mice strains. Thus, MPTP-induced lesions in mice are probably followed by a denervation-like supersensitivity of the dopaminergic system, which might account for the finding that despite a severe degeneration of dopaminergic terminals amphetamine induces hypermotility.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Cell Membrane / metabolism
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dextroamphetamine / pharmacology*
  • Dopamine Agents / toxicity*
  • Dopamine Antagonists / metabolism
  • Immunohistochemistry
  • MPTP Poisoning*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity / drug effects*
  • Receptors, Dopamine D2 / metabolism
  • Spiperone / metabolism
  • Stereotyped Behavior / drug effects
  • Substantia Nigra / drug effects
  • Substantia Nigra / enzymology
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Dopamine Agents
  • Dopamine Antagonists
  • Receptors, Dopamine D2
  • Spiperone
  • Tyrosine 3-Monooxygenase
  • Apomorphine
  • Dextroamphetamine